Stock LUNG PULMONX CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Pulmonx Corporation

Equities

LUNG

US7458481014

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-10 EDT 		5-day change 1st Jan Change
8.41 USD -3.89% Intraday chart for Pulmonx Corporation -14.36% -34.04%
05-01 Earnings Flash (LUNG) PULMONX CORPORATION Posts Q1 Revenue $18.9M, vs. Street Est of $17.9M MT
05-01 Transcript : Pulmonx Corporation, Q1 2024 Earnings Call, May 01, 2024

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GL
Pulmonx : Investor Presentation – May 2024
PU
Earnings Flash (LUNG) PULMONX CORPORATION Posts Q1 Revenue $18.9M, vs. Street Est of $17.9M
MT
Transcript : Pulmonx Corporation, Q1 2024 Earnings Call, May 01, 2024
Pulmonx Reports First Quarter 2024 Financial Results
GL
Pulmonx Corporation Provides Revenue Guidance for the Full Year 2024
CI
Pulmonx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
GL
Pulmonx Appoints Mehul Joshi as Chief Financial Officer
MT
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
GL
Pulmonx Corporation Announces Chief Financial Officer Changes, Effective April 3, 2024
CI
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GL
Pulmonx Announces Treatment of the First Patient with the AeriSeal System in CONVERT II Pivotal Trial
AQ
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial
BU
Pulmonx Corporation Announces Treatment of the First Patient with the Aeriseal System in Convert II Pivotal Trial
CI
North American Morning Briefing : Traders Await -2-
DJ
Pulmonx Shares Fall After Wells Fargo Downgrade
MT
Wells Fargo Downgrades Pulmonx to Equalweight From Overweight, Cuts Price Target to $14 From $16
MT
Canaccord Genuity Adjusts Pulmonx's Price Target to $16 From $12, Keeps Buy Rating
MT
Stifel Adjusts Pulmonx's Price Target to $17 From $15, Keeps Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LUNG Stock
  4. News Pulmonx Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW